Biotechnology market research reports by GlobalData

• Canada Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Canada Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• BRIC Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibro

  Apr 28, 2023  |  Published by: GlobalData  |  USD 3,995

  BRIC Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  France Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  China Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Australia Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Sum ... Read More

• Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Japan Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summary ... Read More

• Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Mexico Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  Brazil Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 Summar ... Read More

• United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to trea

  Apr 28, 2023  |  Published by: GlobalData  |  USD 2,995

  United Kingdom (UK) Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast t ... Read More

• North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uter

  Apr 28, 2023  |  Published by: GlobalData  |  USD 3,995

  North America Embolization Particle Procedures Count by Segments (Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Intrahepatic Cholangiocarcinoma, Embolization Particle Procedures to treat Uterine Fibroids and Others) and Forecast to 2030 ... Read More

• Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031

  Apr 28, 2023  |  Published by: GlobalData  |  USD 9,995

  Melanoma Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for markete ... Read More

• Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031

  Apr 28, 2023  |  Published by: GlobalData  |  USD 9,995

  Ovarian Cancer Cell and Gene Therapy Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs and Forecast to 2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-based forecast (PBF) across the 8MM for m ... Read More

• ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review

  Apr 27, 2023  |  Published by: GlobalData  |  USD 125

  ImmunoGen Inc (IMGN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an ... Read More

• Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review

  Apr 27, 2023  |  Published by: GlobalData  |  USD 125

  Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More

• Metaverse in Healthcare - Thematic Intelligence

  Apr 21, 2023  |  Published by: GlobalData  |  USD 995

  Metaverse in Healthcare - Thematic Intelligence Summary The metaverse will be worth $627 billion by 2030 The metaverse is a virtual world where users share experiences and interact in real-time within simulated scenarios. The metaverse brings together a range of technologies, from cloud computing to ... Read More

• Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review

  Apr 20, 2023  |  Published by: GlobalData  |  USD 125

  Novozymes AS (NZYM B) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a ... Read More

• Beyond the Pill - Key Disruptive Forces in the Healthcare Industry 5.0

  Apr 20, 2023  |  Published by: GlobalData  |  USD 995

  Beyond the Pill - Key Disruptive Forces in the Healthcare Industry 5.0 Summary The healthcare industry is currently experiencing a shift towards remote healthcare, personalized medicine, and preventive care, which is driving a renewed focus on emerging trends such as AI, pharmacogenomics, robotics, ... Read More

• Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review

  Apr 17, 2023  |  Published by: GlobalData  |  USD 125

  Seagen Inc (SGEN) - Financial and Strategic SWOT Analysis Review - provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t ... Read More

• Future of Pharma - Looking Ahead to 2023

  Apr 14, 2023  |  Published by: GlobalData  |  USD 495

  Future of Pharma - Looking Ahead to 2023 Summary This report provides a summary of the near and long-term future of the pharmaceutical industry from the standpoint of drug development. It provides a high-level analysis of key trends and movements within the industry via regulatory, clinical, and mar ... Read More

• Bone Cement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033

  Apr 07, 2023  |  Published by: GlobalData  |  USD 7,500

  Bone Cement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast to 2033 Summary Bone Cement Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, ... Read More

• Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031

  Feb 14, 2023  |  Published by: GlobalData  |  USD 9,995

  Head and Neck Squamous Cell Carcinomas (HNSCC) Market Size and Trend Report including Epidemiology and Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031 Summary This report includes an assessment of the disease epidemiology and 10-year patient-b ... Read More

• GenapSys Inc - Product Pipeline Analysis, 2022 Update

  Feb 07, 2023  |  Published by: GlobalData  |  USD 750

  Summary GenapSys Inc (GenapSys) is engaged in the development of DNA sequencing technologies for applied genomic testing, and medical sequencing. The company offers a Gene Electronic Nano-Integrated Ultra-Sensitive (GENIUS) technology platform that identifies the genome and delivers the insights of ... Read More

• Burning Rock Biotech Ltd (BNR) - Product Pipeline Analysis, 2022 Update

  Feb 07, 2023  |  Published by: GlobalData  |  USD 750

  Summary Burning Rock Biotech Ltd (BRB) is a biotechnology company. It is involved in providing individualized cancer treatment guidance for the patients. The company offers core products such as OncoCompass IO, OncoScreen IO, OncoCompass Target, OncoScreen ParpMatch, Lung Core, Colon Core, Prostate ... Read More

• Qualizyme Diagnostics GmbH & Co KG - Product Pipeline Analysis, 2022 Update

  Feb 07, 2023  |  Published by: GlobalData  |  USD 750

  Summary Qualizyme Diagnostics GmbH & Co KG (Qualizyme Diagnostics), formerly Infact GesbR, is a biotechnology company that discovers and develops medical rapid tests to diagnose infectious diseases. It offers a series of biochemical substrates which include dyed lysozyme substrate and a pH-responsiv ... Read More

• BioTex Inc - Product Pipeline Analysis, 2022 Update

  Feb 07, 2023  |  Published by: GlobalData  |  USD 750

  Summary BioTex Inc (BioTex) operates as a medical device company that designs, develops, manufactures and distributes electro-mechanical, optical and software based devices. The company offers sterile and non-sterile disposable products for surgical, non-surgical and interventional procedures in dia ... Read More

< prev 6 7 8 9 10 11 12 13 14 next >